Skip to main content
SpringerLink
Log in

Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Utilizing a specific “low substrate concentration technique”, intrasynaptosomal MAO-A and MAO-B activities within the rat brain noradrenaline system were studied. It was found that mainly MAO-A was localized intrasynaptosomally, whereas MAO-B contributed with less than 15% of the total intrasynaptosomal MAO activity, a phenomenon that was also observed within the central dopamine system. It is suggested that the intrasynaptosomal pool of MAO in the noradrenaline and the dopamine systems may reflect the density of innervation of the respective system throughout the brain. In addition, the effects of various selective monoamine oxidase (MAO) inhibitors on the noradrenergic intrasynaptosomal MAO activity as well as on the neuronal firing rate of noradrenaline containing cells in the locus coeruleus (LC) were investigated. Pretreatment with the MAO-A selective inhibitors clorgyline (10 mg/kg, i.p., 1 h) or (+)-FLA 336 (1 mg/kg, i.p., 1 h) caused a significant depression (40%) of mean spontaneous firing rate of LC neurones, randomly encountered throughout the LC. The MAO-B selective inhibitor pargyline (10 mg/kg, i.p., 1 h) was found to lack effect in this regard. However, pretreatment with (−)-deprenyl (10 mg/kg, i.p., 1 h), equally a selective MAO-B inhibitor, markedly suppressed the spontaneous firing rate of LC units. This inhibition by (−)-deprenyl was blocked by pretreatment with SK&F 525 A (50 mg/kg, i.p., 30 min), an inhibitor of microsomal drug metabolizing enzymes. Thus, the depression of LC units by (−)-deprenyl seems to be executed by a metabolite, e. g. l-amphetamine. Taken together, the present electrophysiological and biochemical results show that the neuronal depression of noradrenaline neurones in the LC by MAO-inhibitors is specifically related to the inhibition of MAO-A. Furthermore, the data indicate a relationship between the activity of intrasynaptosomally located MAO-A and the neuronal activity of central noradrenaline pathways.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aghajanian GK, Cedarbaum JM, Wang RY (1977) Evidence for noradrenaline0mediated collateral inhibition of locus coeruleus neurons. Brain Res 136:570–577

    Google Scholar 

  • Ask A-L, Fagervall I, Ross S (1983) Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 324:79–87

    Google Scholar 

  • Aston-Jones G, Bloom FE (1981a) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1:879–886

    Google Scholar 

  • Aston-Jones G, Bloom FE (1981b) Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environment stimuli. J Neurosci 1:887–900

    Google Scholar 

  • Campbell IC, Gallager DM, Hamburg MA, Tallman JF, Murphy DL (1985) Electrophysiological and receptor studies in rat brain: Effects of clorgyline. Eur J Pharmacol 111:355–364

    Google Scholar 

  • Cedarbaum JM, Aghajanian GK (1978) Activation of locus coeruleus neurons by peripheral stimuli: Modulation by a collateral inhibitory mechanism. Life Sci 23:1383–1392

    Google Scholar 

  • Demarest KT, Smith DJ, Azzaro AJ (1980) The presence of the type A form of monoamineoxidase within nigrostriatal dopamine-containing neurons. J Pharmacol Exp Ther 215:461–468

    Google Scholar 

  • Engberg G, Svensson TH (1979) Amphetamine-induced inhibition of central noradrenergic neurons: A pharmacological analysis. Life Sci 24:2245–2254

    Google Scholar 

  • Engberg G, Oreland L (1985) Tyramine-indcued suppression of central noradrenergic neurons following monoamineoxidase inhibition. Biogenic Amines 2:111–118

    Google Scholar 

  • Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus coeruleus: New evidence of anatomical and physiological specificity. Physiol Rev 63:844–914

    Google Scholar 

  • Fowler CJ (1982) Selective inhibitors of MAO types A and B and their clinical usefulness. Drugs Futurs 7:501–517

    Google Scholar 

  • Fowler CJ, Oreland L (1981) Substrate- and stereoselective inhibition of human brain monoamine oxidase by 4-dimethylamine,2-dimethylpenthylamine (FLA 336). J Pharm Pharmacol 33:403–406

    Google Scholar 

  • Fowler CJ, Oreland L, Callingham BA (1981) The acetylenic MAO inhibitors clorgyline, deprenyl, pargyline and J-508: Their properties and applications. J Pharm Pharmacol 33:341–347

    Google Scholar 

  • Fowler CJ, Wiberg Å, Oreland L, Marcusson J, Winblad B (1980) The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 49:1–20

    Google Scholar 

  • Garrick NH, Murphy DL (1982) Monoamineoxidase type A: Differences in selectivity towards l-norepinephrine compared to scrotonin. Biochem Pharmacol 31:4061–4066

    Google Scholar 

  • Graham AW, Aghajanian GK (1971) Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus cóeruleus. Nature 234:100–102

    Google Scholar 

  • Green AL, El Hait MAS (1980) A new approach to the assessment of the potency of reversible monoamine oxidase inhibitors in vivo, and its application to (+)amphetamine, p-methoxyamphetamine and harmaline. Biochem Pharmacol 29:2781–2789

    Google Scholar 

  • Holz RW, Coyle JT (1974) The effects of various salts temperature, and the alkaloids veratridine and batrachotoxin on the uptake of (3H) dopamine into synaptosomes from striatum. Mol Pharmacol 10:746–758

    Google Scholar 

  • Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmac 17:1285–1287

    Google Scholar 

  • Kato R, Chiesara E, Vassanelli P (1963) Further studies on the inhibition and stimulation of microsomal drug-metabolizing enzymes of rat liver by various compounds. Biochem Pharmacol 13:69–83

    Google Scholar 

  • König JFR, Klippel RA (1970) The rat brain. A stereotaxis atlas of the forebrain and the lower parts of the brain stem. Krieger, New York, pp 162

    Google Scholar 

  • Lai FM (1980) The monoamine oxidase inhibitors clorgyline and l-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations. Biochem Pharmacol 29:2763–2767

    Google Scholar 

  • Levitt P, Pintar JE, Breakefield XO (1982) Immunocytochemical demonstration of monoamincoxidase B in brain astrocytes and serotonergic neurons. Proc Natl Acad Sci USA 79:6385–6389

    Google Scholar 

  • Markwell M-AK, Haas SM, Lieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206–210

    Google Scholar 

  • Nybäck HV, Walters JR, Aghajanian GK, Roth RH (1975) Tricyclic antidepressant: Effects on the firing rate of brain noradrenergic neurons. Eur J Pharmacol 32:302–312

    Google Scholar 

  • Oreland L, Arai Y, Stenström A (1983) Monoamine oxidase activity and localisation in the brain and the activity in relation to psychiatric disorders. In: Ban TA, Freyhan FA, Pichot P, Pöldinger W (eds) Modern problems in pharmacopsychiatry, vol 19. S. Karger, Basel, pp. 246–254

    Google Scholar 

  • Przuntek H, Philippu A (1973) Reduced pressor response to stimulation of the locus coeruleus after lesion of the posterior hypothalamus. Naunyn-Schmiedeberg's Arch Pharmacol 276:119–122

    Google Scholar 

  • Rényi L, Ross SB (1985) Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in the rat brain slices in vitro and ex vivo in relation to their behavioural effects. Acta Pharmacol Toxicol 56:416–426

    Google Scholar 

  • Reynolds GP, Elsworth JD, Blau K, Sandler M, Lees AJ, Stern GM (1978) Deprenyl is metabolized to metamphetamine and amphetamine in man. Br J Clin Pharmacol 6:542–544

    Google Scholar 

  • Scuvee-Moreau JJ, Svensson TH (1982) Sensitivity in vivo of central alpha2- and opiate-receptors after chronic treatment with various antidepressants. J Neural Transm 54:51–60

    Google Scholar 

  • Shaskan EG, Snyder SH (1970) Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J Pharmacol Exp Ther 175:404–416

    Google Scholar 

  • Snyder SH, Coyle JT (1969) Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. J Pharmacol Exp Ther 165:78–86

    Google Scholar 

  • Strolin-Benedetti M, Boucher T, Fowler CJ (1983) The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamineoxidase and their inhibition by cimoxatone, toloxantone and MD 770222. Naunyn-Schmiedeberg's Arch Pharmacol 323:315–320

    Google Scholar 

  • Svensson TH, Usdin T (1978) Feed-back inhibition of brain noradrenaline neurons by tricyclic antidepressants: Alpha-receptor mediation. Science 202:1089–1091

    Google Scholar 

  • Trepel JB, Wyatt RJ, Neff NH (1977) Differential distribution of type A and B monoamine oxidase in neuronal tissues. Eur J Pharmacol 43:373–375

    Google Scholar 

  • Ward DG, Gunn CG (1976) Locus coeruleus complex: elicitation of a pressor response and a brain stem region necessary for its occurrence. Brain Res 107:401–406

    Google Scholar 

  • Wurtman AJ, Axelrod J (1963) A sensitive and specific assay for the estimation of monoamine oxidase. Biochem Pharmacol 12:1439–1441

    Google Scholar 

  • Yang H-Y, Neff NH (1974) The monoamine oxidases of brain: Selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. J Pharmacol Exp Ther 189:733–740

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Göteborg, P.O.B. 33031, S-40033, Göteborg, Sweden

    Lars Oreland & Göran Engberg

Authors
  1. Lars Oreland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Göran Engberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oreland, L., Engberg, G. Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons. Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 235–239 (1986). https://doi.org/10.1007/BF00512935

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00512935

Key words

Search

Navigation